Critical illness polyneuropathy:: risk factors and clinical consequences.: A cohort study in septic patients

被引:285
作者
Garnacho-Montero, J [1 ]
Madrazo-Osuna, J
García-Garmendia, JL
Ortiz-Leyba, C
Jiménez-Jiménez, FJ
Barrero-Almodóvar, A
Garnacho-Montero, MC
Moyano-Del-Estad, MR
机构
[1] Hosp Univ Virgen Del Rocio, Intens Care Unit, Seville 41013, Spain
[2] Hosp Univ Virgen Del Rocio, Dept Clin Neurophysiol, Seville 41013, Spain
关键词
critical illness polyneuropathy; multiple organ dysfunction syndrome; sepsis; electromyography; muscle relaxants; mechanical ventilation;
D O I
10.1007/s001340101009
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To determine risk factors and clinical consequences of critical illness polyneuropathy (CIP) evaluated by the impact on duration of mechanical ventilation, length of stay and mortality. Design: Inception cohort study. Setting: Intensive care unit of a tertiary hospital. Patients: Septic patients with multiple organ dysfunction syndrome requiring mechanical ventilation and without previous history of polyneuropathy Interventions: Patients under-went two scheduled electrophysiologic studies (EPS): on the 10th and 21st days after the onset of mechanical ventilation. Results: Eighty-two patients were enrolled, although nine of them were not analyzed. Forty-six of the 73 patients presented CIP on the first EPS and 4 other subjects were diagnosed with CIP on the second evaluation. The APACHE II scores of patients with and without CIP were similar on admission and on the day of the first EPS. However. days of mechanical ventilation [32.3 (21.1) versus 18.5 (5.8); p = 0.002], length of ICU and hospital stay in patients discharged alive from the ICU as well as in-hospital mortality were greater in patients with CIP (42/50, 84 % versus 13/23, 56.5 %; p = 0.01). After multivariate analysis, independent risk factors were hyperosmolality [odds ratio (OR) 4.8; 95 % confidence intervals (95 % CI) 1.05-24.38: p = 0.046], parenteral nutrition (OR 5.11; 95 % CI 1.14-22.88; p = 0.02), use of neuromuscular blocking agents (OR 16.32; 95 % Cl 1.34-199; p = 0.0008) and neurologic failure (GCS below 10) (OR 24.02; 95 % Cl 3.68-156.7; p < 0.001). while patients with renal replacement therapy had a lower risk for CIP development (OR 0.02; 95 % CI 0.05-0.15; p < 0.001). By multivariate analysis, CIP (OR 7.11; 95 % CI 1.54-32.75; p < 0.007), age over 60 years (OR 9.07; 95 % CI 2.02-40.68; p < 0.002) and the worst renal SOFA (OR 2.18; 95 % CI 1.27-3.74; p < 0.002) were independent predictors of in-hospital mortality. Conclusions: CIP is associated with increased duration of mechanical ventilation and in-hospital mortality. Hyperosmolality, parenteral nutrition. non-depolarizing neuromuscular blockers and neurologic failure can favor CIP development.
引用
收藏
页码:1288 / 1296
页数:9
相关论文
共 37 条
  • [1] *AM COLL CHEST PHY, 1992, CHEST, V101, P1658
  • [2] Behbehani NA, 1999, CHEST, V115, P1627
  • [3] Berek K, 1996, INTENS CARE MED, V22, P849
  • [4] POLYNEUROPATHY IN CRITICALLY ILL PATIENTS
    BOLTON, CF
    GILBERT, JJ
    HAHN, AF
    SIBBALD, WJ
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1984, 47 (11) : 1223 - 1231
  • [5] Sepsis and the systemic inflammatory response syndrome: Neuromuscular manifestations
    Bolton, CF
    [J]. CRITICAL CARE MEDICINE, 1996, 24 (08) : 1408 - 1416
  • [6] Patterns of neurophysiological abnormality in prolonged critical illness
    Coakley, JH
    Nagendran, K
    Yarwood, GD
    Honavar, M
    Hinds, CJ
    [J]. INTENSIVE CARE MEDICINE, 1998, 24 (08) : 801 - 807
  • [7] POLYNEUROPATHY - POTENTIAL CAUSE OF DIFFICULT WEANING
    CORONEL, B
    MERCATELLO, A
    COUTURIER, JC
    DURAND, PG
    HOLZAPFELL, L
    BLANC, PL
    ROBERT, D
    [J]. CRITICAL CARE MEDICINE, 1990, 18 (05) : 486 - 489
  • [8] Acquired neuromuscular disorders in critically ill patients: a systematic review
    De Jonghe, B
    Cook, D
    Sharshar, T
    Lefaucheur, JP
    Carlet, J
    Outin, H
    [J]. INTENSIVE CARE MEDICINE, 1998, 24 (12) : 1242 - 1250
  • [9] MYOPATHY IN SEVERE ASTHMA
    DOUGLASS, JA
    TUXEN, DV
    HORNE, M
    SCHEINKESTEL, CD
    WEINMANN, M
    CZARNY, D
    BOWES, G
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 146 (02): : 517 - 519
  • [10] Critical illness polyneuropathy:: clinical findings and cell culture assay of neurotoxicity assessed by it prospective study
    Druschky, A
    Herkert, M
    Radespiel-Tröger, M
    Druschky, K
    Hund, E
    Becker, CM
    Hilz, MJ
    Erbguth, F
    Neundörfer, B
    [J]. INTENSIVE CARE MEDICINE, 2001, 27 (04) : 686 - 693